Skip to main content

Houston Health Care Innovation Takes Spotlight at Global Summit

Published Aug 12, 2021 by Maggie Martin

Robert Pieroni

Robert Pieroni, Economic Development Director at Central Houston, participated in a virtual panel discussion about innovation on August 11

Josh Sol

Josh Sol, Administrative Director of Innovation and Ambulatory Clinical Systems at Houston Methodist Hospital, was a panelist as part of the HealthTech Beyond Borders virtual event

Leaders from Houston's innovation ecosystem recently told an international audience how the nation's fourth largest city is supporting new technologies, products and services within one of the most robust health care systems in the world. 

Josh Sol, Administrative Director of Innovation and Ambulatory Clinical Systems at Houston Methodist, and Robert Pieroni, Economic Development Director at Central Houston, took part in a panel highlighting health care innovation on August 11. The discussion was part of HealthTech Beyond Borders, a virtual global conference created to help facilitate business opportunities for medical technology companies in the U.S. and Chile. The event also included speakers from innovation hubs in Chicago and Philadelphia.

Here are highlights of what Sol and Pieroni said during the discussion:

On why international health care startups prioritize the Houston market

“There is a tone and shift that we’re seeing in the Houston area that is focusing in on innovation,” said Sol, who noted Houston Methodist's hub alone has drawn interest from innovators all over the world. Methodist is one of 61 member institutions that make up the Texas Medical Center, the largest medical complex in the world. 

Pieroni underscored TMC's world-renowned reputation in health care.

"When you really start looking at it from a scale perspective of patient testing and data, we really dwarf just about every other city around the world, and so it’s something we’re very proud of,” said Pieroni. “It is one of our unique assets that we’re actually building upon to be the Third Coast for Life Sciences.”

On how Houston supports health care startups

"2017 was our awakening to jumpstart the Houston innovation economy," said Pieroni, alluding to how Houston's unsuccessful bid for Amazon's second headquarters, HQ2, was a turning point for the city's innovation ecosystem. "Along that line, we started to create hubs for startups to land with coworking, accelerators, incubators, and really all those wraparound services."

Pieroni pointed to a few of those hubs, including Downtown Launchpad, a 17,000-square-foot innovation hub in the Amegy Bank Houston building on Main with resident partners including startup accelerators MassChallenge and gener8tor, as well as incubator Impact Hub Houston. He also talked about The Ion, the 266,000-square foot hub in the renovated Sears building at the heart of the Innovation District  designed to bring entrepreneurs, corporate and academic communities together in a collaborative space. He also mentioned health care innovation specifically a focus at places like JLABS @ TMC, the startup accelerator and biotech incubator that serves as the largest JLABS footprint in the U.S. with over 34,000 square feet of common, wet lab and office space.

Sol acknowledged the health care industry can be challenging for startups to break into, but added founders can find a welcoming environment in Houston. 

"Getting into a health care organization is definitely hard, especially to start doing pitches," he said. "I would say there is a flavor and a change that’s happening in the [Texas Medical Center] where it’s a little bit easier to get your companies in to pitch to an innovation team.” 

Sol also touched on the impact COVID-19 has had on the health care industry. 

“Health care is in a digital evolution," he said. "While the pandemic has been tremendously impactful, we’ve seen health care digital adoption increase by 10 years in the span of one because of the pandemic.”

On what early-stage companies need to consider and what steps they need to take to best prepare themselves to receive funding

Pieroni laid out what startups should consider as they pursue funding, including:

  •  Are you VC-backable? "Most startups – it is a term that is so vague now – but most startups think they’re venture-backable. They’re not," he said. "So, it’s really looking at your scale, your opportunity to scale. And then, of course, is it labor intensive? Some of the things you need to think about as you dive into that market.”
     
  • Where are you in the life cycle of getting funding? "Many people think they’re ready for funding when they’re actually not," said Pieroni. "That is one thing that getting into an accelerator - and this kind of goes to the point of deal flow - when you get accepted into an accelerator, it’s an elite group of startups that you’re being accepted into.” He added MassChallenge and gener8tor as examples of these competitive programs, where only 8-11% of startups are accepted. However, applying for accelerator programs is worth the effort, as Pieroni noted that being accepted means the startup has been heavily vetted, which is attractive to potential investors.
     
  • VC is no longer geographically-bound. "It doesn’t matter where you are in the United States. If you have a good product and a good company, you will be funded."
     
  • Do your due diligence on the VC firms you want to target. "A lot of startups throw their decks at venture funds that have no interest in what they do," said Pieroni. He urged startups to research a VC firm's portfolio companies and ensure you wouldn't be a direct competitor, since you'll be sharing valuable information about your startup in your deck.

Pieroni and Sol both encouraged founders to get connected and involved with Houston's innovation ecosystem.

On VC investment growth in Houston

Houston has already raised $1 billion in venture capital in the first half of 2021. Life sciences and health care have become Houston's top-funded VC-funded industry, ahead of information technology and energy.

"So we have just seen a flood of venture capital money, and I think it’s because we have built these hubs that allow people to go to places to see large concentrations of startups," said Pieroni.
 

Learn more about Houston's health care and life sciences ecosystems. Read about innovation in Houston. Watch a Small Biz Insider interview with Robert Pieroni about Downtown Launchpad.

Related News

Economic Development

Houston Region Asserts Biotech Excellence at BIO International Convention

6/25/25
The Greater Houston Partnership and regional partners showcased Houston’s thriving life sciences and biotechnology ecosystem at the 2025 BIO International Convention in Boston. As the premier annual biotechnology conference in the United States, BIO 2025 drew nearly 20,000 global attendees, offering a powerful platform to highlight the region’s momentum, innovation, and growing opportunities in the sector.    BioHouston, Galveston EDP, Partnership Lake Houston, Pearland EDC, the Sugar Land Office of Economic Development and Tourism and The Woodlands EDP presented the many assets and unique benefits the region offers to biotechnology companies from startup to full-scale, including 8 million square feet of life sciences space, strategic workforce and educational initiatives, as well as an overall favorable approach to incentives and permitting.    "Working alongside the different members of our region and telling the story of the amazing product that Greater Houston has to offer is invigorating," Galveston EDP Executive Director Joshua Owens said. "Being able to showcase our ecosystem to a worldwide audience is an exceptional step toward creating opportunities for the people of Houston."    Recent wins, such as Bionova Scientific's move to The Woodlands and United Therapeutics’ move to Generation Park, serve as testaments to the variety of options for life science businesses in our region. With pronounced capabilities in research and development, manufacturing and innovation, life sciences companies of all kinds can find a welcoming home in the Houston region.    To learn more about our life sciences and biotechnology ecosystem, visit our life sciences page. 
Read More
Health Care

Texas Children’s Hospital, MD Anderson Cancer Center Announce Joint Venture Dedicated to Pediatric Cancer Care

2/21/25
Texas Children’s Hospital and the University of Texas MD Anderson Cancer Center have announced a new joint venture aimed at advancing pediatric cancer treatment.   According to the U.S. Census Bureau, more than 24 percent of Texas' population is under 18 years old, and Texas Oncology reports that over 1,700 children under the age of 20 are diagnosed with cancer, with nearly 200 losing their lives to the disease annually. This makes the need for life-saving treatments more crucial than ever.  By combining the expertise and resources of two of the nation’s leading medical institutions, the partnership will expand access to clinical trials, catalyzing innovative discoveries that can bring treatments to young patients faster.  “The scope and scale of our combined effort will build the world’s preeminent pediatric cancer center, addressing the growing need for excellent patient care and greatly benefiting children with cancer through increased access to care and to clinical trials,” Dr. Peter WT Pisters, president of MD Anderson, said in a press release. “MD Anderson and Texas Children’s offer unique strengths that when brought together will accelerate improved outcomes for patients in Texas and around the world.”  Set to launch in early 2026, the joint venture will prioritize the creation of new facilities designed to enhance the overall patient experience, featuring state-of-the-art medical technology and a “best-in-class healing environment.”  The care team will include 200 Texas Children’s pediatric oncology specialists who are full-time faculty with Baylor College of Medicine and more than 100 MD Anderson pediatric clinicians and researchers.  “This groundbreaking collaboration between two proven leaders in pediatric and cancer care marks the beginning of a new era in the fight against childhood cancer,” Debra Sukin, president and chief executive officer of Texas Children’s, said in the release. “The combined force of our two iconic programs will be led with the nation’s top talent—from clinicians and researchers to nurses and administrative professionals—each committed to realizing the shared mission of eradicating pediatric cancer.”  The initiative will also invest in pediatric oncology education programs, ensuring that the next generation of medical professionals is equipped with the tools and knowledge needed to continue advancing pediatric cancer treatment.  The partnership between Texas Children’s and MD Anderson showcases Houston’s dedication to advancing cancer research and pioneering life-saving treatments. In line with this commitment, MD Anderson furthered its efforts last year through a partnership with Rice University to establish the Cancer Bioengineering Collaborative. This collaboration focuses on both fundamental and translational cancer research, developing cutting-edge technologies for cancer detection and therapy, and securing external funding to support continued research and training.  Learn more about Houston’s life sciences ecosystem. 
Read More

Related Events

Executive Partners